JAMA. 2026 Mar 23. doi: 10.1001/jama.2026.4175. Online ahead of print.
NO ABSTRACT
PMID:41870422 | DOI:10.1001/jama.2026.4175
Categories
Reflections on FDA Draft Guidance on Bayesian Methods in Trials-Protecting Scientific Integrity and Evidentiary Standards
